Evolent Health (EVH) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Evolent Health (EVH) over the last 11 years, with Q3 2025 value amounting to -$140.4 million.
- Evolent Health's Enterprise Value fell 2431.95% to -$140.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$140.4 million, marking a year-over-year decrease of 2431.95%. This contributed to the annual value of -$163.5 million for FY2024, which is 2085.99% up from last year.
- As of Q3 2025, Evolent Health's Enterprise Value stood at -$140.4 million, which was down 2431.95% from -$175.4 million recorded in Q2 2025.
- Over the past 5 years, Evolent Health's Enterprise Value peaked at -$112.9 million during Q3 2024, and registered a low of -$342.0 million during Q4 2021.
- For the 5-year period, Evolent Health's Enterprise Value averaged around -$210.7 million, with its median value being -$206.6 million (2023).
- As far as peak fluctuations go, Evolent Health's Enterprise Value crashed by 13661.95% in 2021, and later surged by 4564.18% in 2024.
- Evolent Health's Enterprise Value (Quarter) stood at -$342.0 million in 2021, then skyrocketed by 40.73% to -$202.7 million in 2022, then decreased by 1.92% to -$206.6 million in 2023, then grew by 20.86% to -$163.5 million in 2024, then increased by 14.13% to -$140.4 million in 2025.
- Its Enterprise Value stands at -$140.4 million for Q3 2025, versus -$175.4 million for Q2 2025 and -$262.8 million for Q1 2025.